CURE Talks Cancer copertina

CURE Talks Cancer

CURE Talks Cancer

Di: CURE Talks Cancer
Ascolta gratuitamente

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.
A weekly podcast powered by CURE, on what we do best: provide Cancer Updates Research and Education.


Each week, you'll hear from patients, survivors, caregivers, advocates or health care professionals regarding the entire cancer continuum - ranging from specific cancer types to side effects to the psychological strains a cancer diagnosis can have on an individual and their loved ones.


As the largest consumer magazine in the United States for patient, survivors and caregivers, we strive to combine science with humanity to make cancer understandable.


To learn more, you can also visit us on Facebook, Twitter and Instagram!


Igiene e vita sana Psicologia Psicologia e salute mentale Scienza Scienze biologiche
  • S8 Ep2: Mariska Hargitay Talks About Her Father's Myeloma
    Sep 8 2026

    Actor and advocate Mariska Hargitay has partnered with Bristol Myers Squibb to launch "Investigating Myeloma," a disease awareness campaign honoring the 20th anniversary of her father Mickey Hargitay's death from multiple myeloma.

    The campaign spotlights the critical unmet needs in myeloma and highlights BMS's CELMoD research — an investigational approach that engages the cell's natural protein removal system to stimulate the immune system and enhance the killing of myeloma cancer cells — as a source of renewed hope for patients and their families.

    Hargitay spoke with CURE about her father's story, why she is speaking out now and what she wants patients to know today.

    Mostra di più Mostra meno
    7 min
  • S8 Ep1: Rob Lowe on His Grandmother's Cancer Journey and Why Clinical Trials Matter
    Aug 31 2026

    In our season 8 premiere, actor and longtime breast cancer advocate Rob Lowe joins CURE Talks Cancer to share his grandmother's breast cancer journey, including the clinical trial that helped prolong her life after she was twice told to get her affairs in order. Rob talks about how watching her journey — alongside his mother's, great-grandmother's and father's own cancer experiences — shaped his family for generations, why he partnered with Lilly on a new clinical trial awareness campaign, and what he wishes every newly diagnosed patient knew before ruling a trial out.

    CURE Talks Cancer is a weekly podcast powered by CURE, on what we do best: Cancer Updates, Research and Education. Each week, you'll hear from patients, survivors, caregivers, advocates or health care professionals regarding the entire cancer continuum — ranging from specific cancer types to side effects to the psychological strains a cancer diagnosis can have on an individual and their loved ones.

    As the largest consumer magazine in the United States for patients, survivors and caregivers, we strive to combine science with humanity to make cancer understandable.

    To learn more, visit us on all socials!

    Mostra di più Mostra meno
    15 min
  • S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments
    Dec 31 2025
    CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berger, who recently spoke at CURE’s Educated Patient® Metastatic Breast Cancer Summit, is an assistant professor of medicine at Columbia University Irving Medical Center Division of Hematology and Medical Oncology and the associate director of breast medical oncology at New York Presbyterian-Hudson Valley Hospital in New York.

    Key points discussed by Berger in the podcast included the importance of personalized medicine, with treatments tailored to tumor and patient characteristics. Immunotherapy, particularly Keytruda (pembrolizumab), is often used, especially for PDL-1 positive patients. PARP inhibitors are recommended for BRCA mutation-positive patients. Antibody-drug conjugates, like Trodelvy (sacituzumab govitecan), are emerging as effective treatments, shown to be superior to chemotherapy in combination with immunotherapy.

    Additionally, patients are encouraged to be active in their treatment decisions, engage in exercise and proper nutrition, and consider enrolling in clinical trials, while caregivers are advised to support patients by understanding their needs and providing appropriate assistance.
    Mostra di più Mostra meno
    15 min
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione